Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2025-12-25 @ 11:18 PM
Study NCT ID:
NCT06217393
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-01-29
First Post:
2023-11-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia
Sponsor:
Abbott
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-24
First Submit QC Date:
None
Study First Post Date:
2024-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-28
Last Update Post Date:
2025-01-29
Last Update Post Date Type:
ACTUAL